National Institute of Integrative Medicine - NIIM’s Post

EACTAIC seminar!  LV unloding in tha heart failure setting Join us to heart what's new!  The most relevant personalities about heart failure TOPIC from Policlinico Sant'Orsola Malpighi in Bologna, and the partecipation of Professor Fabio Guarracino https://lnkd.in/dBvWZyUv

ESC Hotlines! Lots of great trials: FINEARTS-HF - Finerenone in heart failure with mildly reduced and preserved ejection fraction FINE-HEART - Participant-level pooled analysis of finerenone in heart failure and chronic kidney disease trials OCEANIC-AF - Asundexian (XIa inbititor) versus apixaban in patients with atrial fibrillation EPIC-CAD - Edoxaban monotherapy vs. dual antithrombotic therapy for atrial fibrillation and stable coronary arthery disease SENIOR RITA - Older patients with non-ST segment elevation myocardial infarction randomised interventional treatment trial. (wins best acronym award!) STOP-or-NOT - Impact of renin-angiotensin system inhibitors continuation versus discontinuation on postoperative complications: a multicenter randomised, controlled trial https://lnkd.in/er27XJEq

One more day to submit your short talk and poster abstracts #EASD2024!

I had the opportunity to participate and share our work again at the European Atherosclerosis Society Congress. This year we present two studies with the Cardiometabolic Council Group of the Sociedad Argentina de Cardiología and the other with the GAELp(a) Group. I share some comments from them: 1️⃣ In a real world cohort of 👨💼 👩💼 with TD2 and previous ASCVD the systematic use of ezetimibe (independent the type and dose of statin used) could double the chance of reaching LDL-c < 55 mg/dL goal. 2️⃣ In a real world population of 👨💼 👩💼 with TD2 and previous ASCVD or high CV risk, 19% meet the criteria to receive icosapent ethyl for CV risk reduction. 3️⃣ In a cross-sectional case-control study individuals with extremely high levels of Lp(a) exhibit significantly higher risk of subclinical atherosclerosis than those with normal levels. European Atherosclerosis Society

Great lecture on Lithium by Dr. Meyer!

Come to join us at #EuropeanExpertPE meeting in Mainz Oct24. Highest PE experts covering a top scientific program about this life threatening disease, with an overall focus on a #multidisciplinaryapproach, ranging from diagnosis to #interventionaltherapies. At Boston Scientific we are committed to the scientific community to improve PE outcomes, so do not hesitate to contact us if you would like more information about our value proposition. #ExpertPE #PulmonaryEmbolism #CatheterDirectedTherapies #USAT

The @Sanofi symposium will explore “Redefining haemophilia: The central role of thrombin generation.” Join us at 15:45.  #EAHAD2024 #EAHADCongress #Haemophilia 

🏆 Celebrating Thomas Jasny’s Achievement! 🎉 🌟 We are thrilled to announce that our very own Data Science Group Frankfurt member, Thomas Jasny, has won the Young Investigator Award 2024 at EuroELSO! 🏅🔬 📝 Thomas submitted an abstract titled “Extracorporeal Cardiopulmonary Resuscitation for Adult Out-of-Hospital Cardiac Arrest: A Nationwide German Study”. 🌐🚑 Typically, abstracts are displayed as posters; however, Thomas’s abstract received the distinction of being upgraded to an oral presentation. This afforded him the unique opportunity to engage in data discussions alongside esteemed figures within the scientific community. 🌐🔬 📈 Key Findings from the Study: Similar Survival Rates: Patients treated with extracorporeal cardiopulmonary resuscitation (ECPR) had survival rates comparable to those who received regular cardiopulmonary resuscitation (CPR). Hospital Experience: Hospital experience was not found to mortality outcomes. Gender Differences: About 70% percent of all CPR patients were male. The male proportion for ECPR patients was even higher with almost 80%. 📄 Thomas and the team are currently refining the data and preparing a manuscript on this topic. Stay tuned for more updates on this exciting research and visit our website to learn more 👉https://lnkd.in/dRGmF4Ae 📝🔍 #EuroELSO #AwardWinning #DataScience #CardiacArrest #ScienceandInnovation #ECPR EuroELSO European Branch of ELSO, Extracorporeal Life Support Organization

🎥 #SCAI2024 Program Chair J. Dawn Abbott, MD, FSCAI, highlights the top moments from this year’s conference, while #SCAI2025 Program Chair Binita Shah, MD, FSCAI, shares exciting reasons to attend next year! Watch the interview and share your favorite moments from this year and your hopes for 2025 in the comments below! ➡️ https://lnkd.in/guSXGhSt #InterventionalCardiology

Here we are, back from the First Meeting on Project Progress for the ANTHEM (AdvaNced Technologies for Human-centEred Medicine) Project! Last week professor Raffaele Dellacà, PhD Chiara Veneroni, and PhD student Elena Barzanti had the opportunity to participate to this congress and two works involving members of our team were presented: - "Monitoring lung impedance for individualizing mechanical ventilation" In collaboration with Anna Lavizzari and Fabio Mosca (Fondazione IRCCS Ca' Granda Foundation), Emanuela Zannin, Camilla Rigotti and Maria Luisa Ventura (Fondazione IRCCS San Gerardo dei Tintori) and Tobias Werther (Medizinische Universität Wien). - "Preliminary studies on the management of humidity in e-nose sampling systems" In collaboration with Ana Maria Tischer, Beatrice Lotesoriere and Laura Maria Teresa Capelli (Laboratorio Olfattometrico @ PoliMI) #biomed #mechanicalventilation #techres #congress